Metabolic Parameters, Weight Loss, and Comorbidities 4 Years After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy.

Corey J LagerNazanene H EsfandiariYingying LuoAngela R SubausteAndrew T KraftsonMorton B BrownOliver A VarbanRasimcan MeralRuth B CassidyCatherine K NayAmy L LockwoodDarlene BellersColleen M BudaElif Arioglu Oral

Published in: Obesity surgery (2019)

Weight loss, reduction in medications for hypertension and diabetes, improvements in markers of diabetes and hyperlipidemia, and remission rates of hypertension were superior with RYGB vs. LSG 4 years post-operatively. Choice of bariatric procedures should be tailored to surgical risk, comorbidities, and weight loss goals.

Keyphrases

roux en y gastric bypass
weight loss
glycemic control
gastric bypass
bariatric surgery
blood pressure
type diabetes
cardiovascular disease
obese patients
weight gain
high fat diet
disease activity
smoking cessation
rheumatoid arthritis
adipose tissue
physical activity
decision making